Bagcchi S .2023 .. WHO's Global Tuberculosis Report 2022. Lancet Microbe, 4(1) : e20.
Bowers A,Zhou X .2019 .Receiver Operating Characteristic (ROC) Area Under the Curve (AUC): A diagnostic measure for evaluating the accuracy of predictors of education outcomes. J. Educ. Stu. Placed Risk, 24(1) : 20-46.
Cheng X,Zhu J,Li Y,Luo W,Xiang H,Zhang Q,Peng W .2022 .Serum biomarkers of isoniazidinduced liver injury: Aminotransferases are insufficient and OPN, L-FABP and HMGB1 can be promising novel biomarkers. J. Appl. Toxicol., 42(3) : 516-528.
Clinton J,Kiparizoska S,Lewis J .2021 .Druginduced liver injury: Highlights and controversies in the recent literature. Drug saf., 44(11) : 1125-1149.
Dear J,Clarke J,Allen L J .2018 .Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies. Lancet Gastroenterol. Hepatol., 3(2) : 104-113.
Furin J,Cox H,Pai M H .2019 .. Tuberculosis. Lancet, 393(10181) : 1642-1656.
Guldiken N,Usachov V,Levada K,Trautwein C,Ziol M,Nahon P,Strnad P .2015 .Keratins 8 and 18 are type II acute-phase responsive genes overexpressed in human liver disease. Liver Int, 35(4) : 1203-1212.
Guldiken N,Zhou Q,Rehm M .2015 .Human keratin 8 variants promote mouse acetaminophen hepatotoxicity co upled with c-jun amino-terminal kinase activation and protein adduct formation. Hepatology, 62(3) : 876-886.
Harada M,Strnad P,Resurreccion E,Ku N,Omary M .2007 .Keratin 18 overexpression but not phosphorylation or filament organization blocks mouse Mallory body formation. Hepatology, 45 : 88-96.
Howell L,Ireland L,Park B,Goldring C B .2018 .MiR122 and other microRNAs as potential circulating biomarkers of dru g-induced liver injury. Expert Rev. Mol. Diag, 18(1) : 47-54.
Kobayashi T,Iwaki M,Yoneda M M,Clin M .2023 .Epidemiology and management of drug-induced liver Injury: Importance of the Updated RUCAM. , 11(5) : 1239-1245.
Korver S,Bowen J,Pearson K,Gonzalez R,French N,Park K,Jenkins R,French N R .2021 .The application of cytokeratin-18 as a biomarker for druginduced liver injury. Arch. Toxicol., 95(11) : 3435-3448.
Lewis J,Korkmaz S,Copeland M .2024 .Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat Mycobacterium tuberculosis. Expert Opin, 23(9) : 1093-1107.
Lim Y,Ku N Y .2021 .Revealing the roles of keratin 8/18-associated signaling proteins involved in the development of hepatocellular carcinoma. Int. J. Mol. Sci, 22(12) : 6401.
Omary M,Ku N,Toivola D .2002 .Keratins: guardians of the liver. Hepatology, 35(2) : 251-257.
Qian H and Ding W .2023 .SQSTM1/p62 and hepatic mallory-denk body formation in alcohol-associated Liver Disease. Am. J. Pathol., 193(10) : 1415-1426.
Ravindra K,Vaidya V,Wang Z,Ramaiah S Z .2023 .Tandem mass tag-based quantitative proteomic profiling identifies cand idate serum biomarkers of drug-induced liver injury in humans. Nat. commun., 14(1) : 1215.
Rupprechter S,Sloan D,Oosthuyzen W,Bachmann T,Hill A,Dhaliwal K,Templeton K,Matovu J,Sekaggya W,Bachmann T .2021 .MicroRNA-122 and cytokeratin-18 have potential as a biomarkers of druginduced liver injury in European and African patients on treatment for mycobacterial infection. Br. J. Clin. Pharmacol, 87(8) : 3206-3217.
Singampalli K,Li J,Lillehoj P .2022 .Rapid magneto-enzyme-linked immunosorbent assay for ultrasensitive protein detection. Anal. Chim. Acta, 1225 : 340246.
Suárez I,Funger S,Kröger S,Rademacher J,Fätkenheuer G,Rybniker J .2019 .The Diagnosis and Treatment of Tuberculosis. , 116(43) : 729-735.
Tajima S,Yamamoto N,Masuda S N .2019 .Clinical prospects of biomarkers for the early detection and/or prediction of organ injury associated with pharmacotherapy. Biochem. Pharmacol., 170 : 113664.
Tamber S,Bansal P,Sharma R .2023 .Biomarkers of liver diseases. Mol. Biol. Rep, 50(9) : 7815-7823.
Thulin P,Nordahl G,Aklillu E .2014 .Keratin-18 and microRNA-122 complement alanine aminotransferase as nov el safety biomarkers for drug-induced liver injury in two human cohorts. Liver Int, 34(3) : 367-378.
Tostmann A,Boeree M,Dekhuijzen R M .2008 .Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review. J. Gastroenterol. Hepatol., 23(2) : 192-202.
Wang B,Yang W,Meyers M .2016 .Keratin: Structure, mechanical properties, occurrence in biological organisms, and efforts at bioinspiration. Prog. Mater. Sci., 76 : 229-318.
Wang P,Chen Y,Fan H Y .2021 .Keratin 18 induces proliferation, migration and invasion in gastric cancer via the MAPK signalling pathway. Clin. Exp. Pharmacol. Physiol., 48(1) : 147-156.
Wu Y,Zhou J,Li H J .2024 .Cytokeratin 18 in nonalcoholic fatty liver disease: value and application. Expert Rev. Mol. Diagn, 24(11) : 1009-1022.
Xiang H,Li Y,Cheng X,He B,Li H,Zhang Q,Wang B,Zhang Q .2023 .Serum levels of IL-6/IL10/GLDH may be early recognition markers of antituberculosis drugs (ATB)-induced liver injury. Toxicol. Appl, 475 : 116635.
Yu Y,Mao Y,Cong W Y .2017 .CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol. Int., 11(3) : 221-241.